为了推动国内多肽研究的发展,我们现在特将我们能够提供或者曾经提供的修饰介绍给大家.欢迎来电询价.
| Item A | Modification |
| A1 | Acetylation (N-Terminal) |
| A2 | Fmoc(N-Terminal) |
| A3 | Amidation (C-Terminal) |
| A4 | Z (CBZ) (N-Terminal) |
| A5 | Bz (N-Terminal) |
| A7 | Br-Ac- {N terminus)} |
| A8 | Formylation (N-Terminal) |
| A9 | Fatty acid (N-Terminal) |
| A10 | Myristic acid (N-Terminal) |
| A11 | Palmytolyl (N-Terminal) |
| A12 | Suc (N-Terminal) |
| A13 | pNA (C-Terminal) |
| A14 | AMC ( C-Terminal) |
| A15 | CMK (C-Terminal) |
| A16 | FMK (C-Terminal) |
| A17 | Cysteamide ( C-Terminal) |
| A18 | {HPP},3-(p-Hydroxyphenyl)propionic Acid (N-Terminal) |
| A19 | {Mpa} (N-Terminal) |
| A20 | {pGlu} (N-Terminal) |
| A21 | DL-Lipoic acid (N-Terminal) |
| A22 | {Maleoyl-b-Ala}, Maleimide (N-Terminal) |
| Item B | Special amino acid |
| B1 | {D-2-Me-Trp} |
| B2 | {Ser(octanoic acid)} |
| B3 | {Lys(Me)} |
| B4 | {Lys(Me2)} |
| B5 | {Lys(Me3)} |
| B6 | {Lys(Dde)} |
| B7 | {Lys(Alloc)} |
| B8 | {D-Ile} |
| B9 | {D-Orn} |
| B10 | {D-Gln} |
| B11 | {D-Cit} |
| B12 | {Dab} |
| B13 | {Dap} |
| B14 | {D-Beta-Asp} |
| B15 | {D-Gama-Glu} |
| B16 | {D-Arg} |
| B17 | {D-Cys} |
| B18 | {D-Asp} |
| B19 | {D-Asn} |
| B20 | {D-Glu} |
| B21 | {D-Ser} |
| B22 | {D-His} |
| B23 | {D-Tyr} |
| B24 | {D-Thr} |
| B25 | {D-Trp} |
| B26 | {D-Lys} |
| B27 | {Orn} |
| B28 | {Abu} |
| B29 | {Aib} |
| B30 | {Nva} |
| B31 | {Nle} |
| B32 | {Cit} |
| B33 | {Lys(Ac)} |
| B34 | {Cys(Me)}, SMC |
| B35 | {Cys(Cam)} |
| B36 | {Cys(Acm)} |
| B37 | {Cys(tBu)} |
| B38 | {Hse} |
| B39 | {Hcy} |
| B40 | {D-Pen} |
| B41 | {Cha} |
| B42 | {D-Cha} |
| B43 | {Chg} |
| B44 | {D-Chg} |
| B45 | {D-1-Nal} |
| B46 | {L-1-Nal} |
| B47 | {D-2-Nal} |
| B48 | {L-2-Nal} |
| B49 | {D-2-Pal} |
| B50 | {L-2-Pal} |
| B51 | {D-3-Pal} |
| B52 | {L-3-Pal} |
| B53 | {D-4-Pal} |
| B54 | {L-4-Pal} |
| B55 | {D-4-Cl-Phe} |
| B56 | {L-4-Cl-Phe} |
| B57 | {D-4-F-Phe} |
| B58 | {L-4-F-Phe} |
| B59 | {D-4-NO2-Phe} |
| B60 | {L-4-NO2-Phe} |
| B61 | {D-4-I-Phe} |
| B62 | {L-4-I-Phe} |
| B63 | {Beta-Asp} |
| B64 | {Gama-Glu} |
| B65 | {D-Ala} |
| B66 | {D-Leu} |
| B67 | {D-Met} |
| B68 | {D-Pro} |
| B69 | {D-Phe} |
| B70 | {D-Val} |
| B71 | {Hyp} |
| B72 | {Phg} |
| Item C | Spacer Linker |
| C1 | {Mini-PEG} |
| C2 | {Ava}, C5 |
| C3 | {Ahx}, C6 |
| C4 | {GABA}, C4 |
| C5 | {Beta-Ala}, C3 |
| C6 | {Gly}, C2 |
| Item D | N-Methyl amino acid |
| D1 | {N-Me-Ala} |
| D2 | {N-Me-Phe} |
| D3 | {N-Me-Leu} |
| D4 | {N-Me-Ile} |
| D5 | {N-Me-Val} |
| D6 | {N-Me-Met} |
| D7 | {N-Me-Nle} |
| D8 | {N-Me-Nva} |
| D9 | {N-Me-Gly}, Sar |
| D10 | {N-Me-Ser} |
| D11 | {N-Me-Tyr} |
| D12 | {N-Me-Thr} |
| D13 | {N-Me-Asp} |
| D14 | {N-Me-Glu} |
| Item E | Phosphorylation |
| E1 | {pSer} |
| E2 | {pTyr} |
| E3 | {pThr} |
| E4 | Di-sites in sequence |
| E5 | Tri-sites in sequence |
| Item F | Fluorescence/Dye Labeling |
| F1 | Biotin (N-Terminal) |
| F2 | Biotin-LC (N-Terminal) |
| F3 | 3-Indolylacetic acid |
| F4 | FITC (N-Terminal) |
| F5 | FITC-LC (N-Terminal) |
| F6 | 5-FAM (N-Terminal) |
| F7 | 5-FAM-LC (N-Terminal) |
| F8 | Dansyl (N-Terminal) |
| F9 | Dansyl-LC (N-Terminal) |
| F10 | MCA (N-Terminal) |
| F11 | TMR (N-Terminal) |
| F12 | Lys(Biotin) (middle) |
| F13 | Lys(Biotin) (C temrinus) |
| F14 | Lys(FITC) (middle) |
| F15 | Lys(FITC) (C temrinus) |
| F16 | Lys(5-FAM) (middle) |
| F17 | Lys(5-FAM) (C temrinus) |
| F18 | Lys(Dansyl) (middle) |
| F19 | Lys(Dansyl) (C temrinus) |
| F20 | Lys(TMR) (middle) |
| F21 | Lys(TMR) (C temrinus) |
| F22 | {Lys(Dnp)} (middle) |
| F23 | EDBiotin (C terminus) |
| F24 | EDDnp (C terminus) |
| F25 | {Lys(Maleimide)}, (middle) |
| Item G | Cyclic peptide |
| G1 | Mono Disulfide bridge |
| G2 | Double Disulfide bridge |
| G3 | Triple Disulfide bridge |
| G4 | Same Seq. Inter-Disulfide bridge |
| G5 | Different Inter-Disulfide bridge |
| G6 | Amide cyclic (end) |
| G7 | Amide cyclic (Side chain) |
| Item H | Quenched fluorescent peptide |
| H1 | Abz/ Tyr (3-NO2) |
| H2 | Abz |
| H3 | Tyr (3-NO2) |
| H4 | Glu(EDANS)-NH2 |
| H5 | DABCYL |
| H6 | DABCYL/Glu(EDANS)-NH2 |
| Item I | MAPS and Carrier Complex |
| I1 | Asymmetric 2 Branches (Pure) |
| I2 | Asymmetric 4 Branches (Crude) |
| I3 | Asym metric 8 Branches (Crude) |
| I4 | Glu 2 Branches (Pure) |
| I5 | n-mer Branch peptide on Lys side chain (Pure) |
| I6 | KLH-Peptide |
| I7 | BSA-Peptide |
| Item J | C Terminus Modification |
| Item Ja | C terminus ended amino acids: Ala, Gly, Met, Leu, Ile, Phe, Pro, Val |
| Ja1 | -OMe (C-terminal) |
| Ja2 | -OEt (C-terminal) |
| Ja3 | -OBzl (C-terminal) |
| Ja4 | -OtBu (C-terminal) |
| Ja5 | -TBzl (C-terminal) |
| Ja6 | -NHMe (C-terminal) |
| Ja7 | -NHEt (C-terminal) |
| Ja8 | -NHisopen (C-terminal) |
| Item Jb | C terminus ended amino acids: Lys, Gln, Asn, Cys, His, Arg, Ser, Thr, Tyr, Trp, Asp, Glu |
| Jb1 | -OMe (C-terminal) |
| Jb2 | -OEt (C-terminal) |
| Jb3 | -OBzl (C-terminal) |
| Jb4 | -OtBu (C-terminal) |
| Jb5 | -TBzl (C-terminal) |
| Jb6 | -NHMe (C-terminal) |
| Jb7 | -NHEt (C-terminal) |
| Jb8 | -NHisopen (C-terminal) |
| Item K | Aliquoting |
| Item L | GMP Clean Room Process |
| Item M | Amino Acid Analysis (AAA) |
| Item N | N elemental Analysis |
| Item O | Solubility test |
| Item P | Microbial analysis |
| Item Q | Water content (Karl Fischer) |
| Item R | Acetate Content (HIPC) |
| Item S | Maldi-Tof MS |
| Item T | Endotoxin analysis |